| # | Drug | Count |
|---|---|---|
| 0 | INSULIN LISPRO | 137 |
| 1 | INSULIN GLARGINE | 125 |
| 2 | INSULIN HUMAN | 69 |
| 3 | INSULIN ASPART | 32 |
| 4 | ASPIRIN | 24 |
| 5 | ASPIRIN 325 MG | 24 |
| 6 | ASPIRIN 81 MG | 24 |
| 7 | INSULIN | 24 |
| 8 | EXENATIDE | 20 |
| 9 | METFORMIN | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INSULIN HUMAN | 69 | 0.0017 |
| 1 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 2 | GLUCAGON | 5 | 0.0012 |
| 3 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 4 | HUMAN INSULIN | 8 | 0.0011 |
| 5 | MIGLITOL | 1 | 0.0010 |
| 6 | INSULIN LISPRO | 137 | 0.0010 |
| 7 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 8 | INSULIN GLULISINE | 7 | 0.0007 |
| 9 | INSULIN GLARGINE-YFGN | 15 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 238 |
| 1 | Insulin [EPC] | 76 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 3 | GLP-1 Receptor Agonist [EPC] | 26 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 5 | Sulfonylurea [EPC] | 15 |
| 6 | Benzodiazepine [EPC] | 14 |
| 7 | Proton Pump Inhibitor [EPC] | 14 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| 9 | Vitamin C [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin [EPC] | 76 | 0.0016 |
| 1 | Antihypoglycemic Agent [EPC] | 5 | 0.0012 |
| 2 | Insulin Analog [EPC] | 238 | 0.0005 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 6 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 7 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 8 | Sulfonylurea [EPC] | 15 | 0.0001 |
| 9 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |